Myelodysplastic syndromes and acute myeloid leukemia in cats infected with feline leukemia virus clone33 containing a unique long terminal repeat

International Journal of Cancer

Volumn 124, Issue 5, 2009, Pages 1133-1141

  Hisasue, Masaharu ^a   Nagashima, Naho ^a   Nishigaki, Kazuo ^b   Fukuzawa, Isao ^c   Ura, Shigeyoshi ^c   Katae, Hiromi ^d   Tsuchiya, Ryo ^a   Yamada, Takatsugu ^a   Hasegawa, Atsuhiko ^e   Tsujimoto, Hajime ^e  

^a AZABU UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c Kyodoken Institute   (Japan)

^d Osaka City University   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

AML; Leukemia; LTR; MDS; Pathogenesis; Retrovirus

Indexed keywords

ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SURVIVIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; ERYTHROID CELL; EXPERIMENTAL CAT; FELINE LEUKEMIA VIRUS; GENE EXPRESSION; MYELODYSPLASTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANIMAL DISEASE; BONE MARROW; CAT; CAT DISEASE; GENETICS; LONG TERMINAL REPEAT; METABOLISM; PATHOLOGY;

ANIMALS; BONE MARROW; CATS; LEUKEMIA VIRUS, FELINE; LEUKEMIA, FELINE; LEUKEMIA, MYELOID, ACUTE; MYELODYSPLASTIC SYNDROMES; TERMINAL REPEAT SEQUENCES;

EID: 58749103173     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24050     Document Type: Article

References (47)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189 - 99.
2. Hisasue M, Okayama H, Okayama T, Suzuki T, Mizuno T, Fujino Y, Naganobu K, Hasegawa A, Watari T, Matsuki N, Masuda K, Ohno K, et al. Hematologic abnormalities and outcome of 16 cats with myelodysplastic syndromes. J Vet Intern Med 2001;15:471 - 77.
3. Hisasue M, Nishigaki K, Katae H, Yuri K, Mizuno T, Fujino Y, Setoguchi A, Hasegawa A, Watari T, Masuda K, Ohno K, Tsujimoto H. Clonality analysis of various hematopoietic disorders in cats naturally infected with feline leukemia virus. J Vet Med Sci 2000;62:1059 - 65.
4. Nagashima N, Hisasue M, Higashi K, Kano R, Tsujimoto H, Hasegawa A. Bone marrow colony-forming unit assay in cats with naturally occurring myelodysplastic syndromes. Int J Hematol 2001; 73:453 - 56.
5. Shimoda T, Shiranaga N, Mashita T, Hasegawa A. A hematological study on thirteen cats with myelodysplastic syndrome. J Vet Med Sci 2000;62:59 - 64.
6. Shimoda T, Shiranaga N, Mashita T, Hasegawa A. Chronic myelomonocytic leukemia in a cat. J Vet Med Sci 2000;62:195 - 97.
7. Jain NC, Blue JT, Grindem CB, Harvey JW, Kociba GJ, Krehbiel JD, Latimer KS, Raskin RE, Thrall MA, Zinkl JG. Proposed criteria for classification of acute myeloid leukemia in dogs and cats. Vet Clin Pathol 1991;20:63 - 82.
8. Raskin RE. Myelopoiesis and myeloproliferative disorders. Vet Clin North Am Small Anim Pract 1996;26:1023 - 42.
9. Jain N. Classification of myeloproliferative disorders in cats using criteria proposed by the animal leukemia study group: a retrospective study of 181 cases (1969 - 1992). Comp Haematol Int 1993; 3:125 - 34.
10. Shimada T, Matsumoto Y, Okuda M, Momoi Y, Bonkobara M, Watari T, Watari T, Goitsuka R, Ono K, Goto N, Tsujimoto H, Hasegawa A. Erythroleukemia in two cats naturally infected with feline leukemia virus in the same household. J Vet Med Sci 1995;57:199 - 204.
11. Linenberger ML, Abkowitz JL. Haematological disorders associated with feline retrovirus infections. Baillieres. Clin Haematol 1995;8:73 - 112.
12. Donahue PR, Hoover EA, Beltz GA, Riedel N, Hirsch VM, Overbaugh J, Mullins JI. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol 1988;62:722 - 31.
13. Stewart MA, Warnock M, Wheeler A, Wilkie N, Mullins JI, Onions DE, Neil JC. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J Virol 1986;58:825 - 34.
14. Nishigaki K, Okuda M, Endo Y, Watari T, Tsujimoto H, Hasegawa A. Structure and function of the long terminal repeats of feline leukemia viruses derived from naturally occurring acute myeloid leukemias in cats. J Virol 1997;71:9823 - 27.
15. Matsumoto Y, Momoi Y, Watari T, Goitsuka R, Tsujimoto H, Hasegawa A. Detection of enhancer repeats in the long terminal repeats of feline leukemia viruses from cats with spontaneous neoplastic and nonneoplastic diseases. Virology 1992;189:745 - 9.
16. Riedel N, Hoover EA, Gasper PW, Nicolson MO, Mullins JI. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. J Virol 1986;60:242 - 50.
17. Fulton R, Plumb M, Shield L, Neil JC. Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. J Virol 1990;64:1675 - 82.
18. Miura T, Shibuya M, Tsujimoto H, Fukasawa M, Hayami M. Molecular cloning of a feline leukemia provirus integrated adjacent to the cmyc gene in a feline T-cell leukemia cell line and the unique structure of its long terminal repeat. Virology 1989;169:458 - 61.
19. Overbaugh J, Donahue PR, Quackenbush SL, Hoover EA, Mullins JI. Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science 1988;239:906 - 10.
20. Chandhasin C, Coan PN, Pandrea I, Grant CK, Lobelle-Rich PA, Puetter A, Levy LS. Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome. J Virol 2005;79:5278 - 87.
21. Nishigaki K, Hanson C, Thompson D, Yugawa T, Hisasue M, Tsujimoto H, Ruscetti S. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus. J Virol 2002; 76:1527 - 32.
22. Ramsey IK, Spibey N, Jarrett O. The receptor binding site of feline leukemia virus surface glycoprotein is distinct from the site involved in virus neutralization. J Virol 1998;72:3268 - 77.
23. Jarrett O, Ganiere JP. Comparative studies of the efficacy of a recombinant feline leukaemia virus vaccine. Vet Rec 1996;138:7 - 11.
24. Clinkenbeard KD, Meinkoth JH. Normal hematology of the cat. In: Feldman BF, Zinkl JG, Jain NC, eds. Veterinary hematology, 5th edn. Maryland: Lippincott Williams&Wilkins, 2000. 1064 - 8.
25. Harley R, Helps CR, Harbour DA, Gruffydd-Jones TJ, Day MJ. Cytokine mRNA expression in lesions in cats with chronic gingivostomatitis. Clin Diagn Lab Immunol 1999;6:471 - 8.
26. Tzavaras T, Stewart M, McDougall A, Fulton R, Testa N, Onions DE, Neil JC. Molecular cloning and characterization of a defective recombinant feline leukaemia virus associated with myeloid leukaemia. J Gen Virol 1990;71 (Part 2):343 - 4.
27. Rosenberg N, Jolicoeur P. Retroviral pathogenesis. In: Coffin JM, Hughes SH, Varmus HE, eds. Retroviruses, 1st edn. New York: Cold Spring Harbor Laboratory, 1997. 475 - 586.
28. Linman JW, Bagby C Jr. The preleukemic syndrome: clinical and laboratory features, natural course, and management. Nouv Rev Fr Hematol Blood Cells 1976;17:11 - 31.
29. Nagashima N, Hisasue M, Nishigaki K, Miyazawa T, Kano R, Hasegawa A. In vitro selective suppression of feline myeloid colony formation is attributable to molecularly cloned strain of feline leukemia virus with unique long terminal repeat. Res Vet Sci 2005;78: 151 - 4.
30. Chandhasin C, Lobelle-Rich P, Levy LS. Feline leukaemia virus LTR variation and disease association in a geographical and temporal cluster. J Gen Virol 2004;85 (Part 10):2937 - 42.
31. Dan K, An E, Futaki M, Inokuchi K, Gomi S, Yamada T, Ogata K, Tanabe Y, Ohki I, Shinohara T. Megakaryocyte, erythroid and granulocyte- macrophage colony formation in myelodysplastic syndromes. Acta Haematol 1993;89:113 - 8.
32. Backx B, Broeders L, Touw I, Lowenberg B. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors. Leukemia 1993;7:75 - 9.
33. Ohmori M, Ohmori S, Ueda Y, Yoshida Y, Okuma M. Ineffective hemopoiesis in the myelodysplastic syndromes (MDS) as studied by daily in situ observation of colony-cluster formation. Int J Cell Cloning 1991;9:521 - 30.
34. Tennant GB, Bowen DT, Jacobs A. Colony-cluster ratio and cluster number in cultures of circulating myeloid progenitors as indicators of high-risk myelodysplasia. Br J Haematol 1991;77:296 - 300.
35. Raza A, Mundle S, Shetty V, Alvi S, Chopra H, Span L, Parcharidou A, Dar S, Venugopal P, Borok R, Gezer S, Showel J, et al. Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines. Int J Hematol 1996;63:265 - 78.
36. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917 - 21.
37. Chakravarti A, Zhai GG, Zhang M, Malhotra R, Latham DE, Delaney MA, Robe P, Nestler U, Song Q, Loeffler J. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 2004;23:7494 - 506.
38. Meng H, Lu C, Mabuchi H, Tanigawa N. Prognostic significance and different properties of survivin splicing variants in gastric cancer. Cancer Lett 2004;216:147 - 55.
39. Krajewska M, Krajewski S, Banares S, Huang X, Turner B, Bubendorf L. Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res 2003;9:4914 - 25.
40. Wakana Y, Kasuya K, Katayanagi S, Tsuchida A, Aoki T, Koyanagi Y, Ishii H, Ebihara Y. Effect of survivin on cell proliferation and apoptosis in gastric cancer. Oncol Rep 2002;9:1213 - 8.
41. Boudard D, Vasselon C, Bertheas MF, Jaubert J, Mounier C, Reynaud J, Viallet A, Chautard S, Guyotat D, Campos L. Expression and prognostic significance of Bcl-2 family proteins in myelodysplastic syndromes. Am J Hematol 2002;70:115 - 25.
42. Allampallam K, Shetty V, Hussaini S, Mazzoran L, Zorat F, Huang R, Raza A. Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes. Anticancer Res 1999;19:5323 - 8.
43. Shetty V, Mundle S, Alvi S, Showel M, Broady-Robinson L, Dar S, Borok R, Showel J, Gregory S, Rifkin S, Gezer S, Parcharidou A, et al. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res 1996;20:891 - 900.
44. Ali A, Mundle SD, Ragasa D, Reza S, Shetty V, Mativi BY, Cartlidge JD, Azharuddin M, Qawi H, Dar S, Raza A. Sequential activation of caspase-1 and caspase-3-like proteases during apoptosis in myelodysplastic syndromes. J Hematother Stem Cell Res 1999;8:343 - 56.
45. Mundle SD, Reza S, Ali A, Mativi Y, Shetty V, Venugopal P, Gregory SA, Raza A. Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes. Cancer Lett 1999;140:201 - 7.
46. Aizawa S, Nakano M, Iwase O, Yaguchi M, Hiramoto M, Hoshi H, Nabeshima R, Shima D, Handa H, Toyama K. Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro. Leuk Res 1999;23:239 - 46.
47. Aizawa S, Hiramoto M, Hoshi H, Toyama K, Shima D, Handa H. Establishment of stromal cell line from an MDS RA patient which induced an apoptotic change in hematopoietic and leukemic cells in vitro. Exp Hematol 2000;28:148 - 55.